Metabolic Tumour Volume from PSMA PET/CT Scans of Prostate Cancer Patients during Chemotherapy—Do Different Software Solutions Deliver Comparable Results?

Metabolic Tumour Volume from PSMA PET/CT Scans of Prostate Cancer Patients during Chemotherapy—Do Different Software Solutions Deliver Comparable Results?

(1) Background: Prostate-specific membrane antigen (PSMA)-derived tumour volume (PSMA-TV) and total lesion PSMA (TL-PSMA) from PSMA PET/CT scans are promising biomarkers for assessing treatment response in prostate cancer (PCa). Currently, it is unclear whether different software tools for assessing...

Full description

Bibliographic Details
Main Authors: Philipp E. Hartrampf, Marieke Heinrich, Anna Katharina Seitz, Joachim Brumberg, Ioannis Sokolakis, Charis Kalogirou, Andreas Schirbel, Hubert Kübler, Andreas K. Buck, Constantin Lapa, Markus Krebs
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Journal of Clinical Medicine
Subjects:
prostate-specific membrane antigen (PSMA)
metabolic tumour volume (MTV)
total lesion PSMA
biomarker
software
comparability
Online Access:https://www.mdpi.com/2077-0383/9/5/1390

Internet

https://www.mdpi.com/2077-0383/9/5/1390

Similar Items